Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Ind
k
NATIONAL
MEDICINES POLICY
2006
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
and
preparation
Guidance
of
in
the
National
support
Medicines
of
revision
Policy
(KONAS)
and
re-
is
now
completed.
of
international
trade
spreading
pharmaceutical
particularly
on
medicine
i.e.
financing,
research
monitoring
and
and
development,
evaluation.
All
human
resource
represent
the
Living
and
the
Mission
of
Ministry
of
Health
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
OFFICIAL ACKNOWLEDGEMENT
MINISTER OF HEALTH REPUBLIC OF INDONESIA
Health
refers
to
human
rights
and
each
member
of
declining
entry
barrier
of
international
trade
cause
Medicine
materials
applied
system
or
is
to
pathology
prevention,
contraception
healing,
single
material
or
mixtures
of
influence
or
investigate
physiology
condition
in
determining
diagnosis,
recovery,
including
improvement
biological
of
health
and
products.
Access
to
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
been
established
by
Law
No.23
on
Health,
Government
In
the
subsystem
National Health
of
Medicines
System, emphasis is
and
Medical
Supply
in
given on availability,
medicines,
controlling,
research
and
development,
human
organization,
business
segment,
professional
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
assistance,
inputs
and
contribution
in
preparing
National
Medicines Policy.
May God the Almighty bestow His Blessedness and Charity
in
the
realization
of
Creating
Healthy
Communities
in
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
TABLE OF CONTENTS
FOREWORD
OFFICIAL ACKNOWLEDGEMENT OF MINISTER OF HEALTH
TABLE OF CONTENTS
I.
INTRODUCTION
A. Background
B. Objectives
C. Scope
II.
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
CLOSING
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
Considering :
a.
whereas,
in
anticipating
the
changes
external,
Health
in
System,
necessary
line
it
to
is
with
National
considered
establish
as
national
medicines policy;
b.
whereas,
in
consideration
of
the
2.
Law
Number
(Supplement
23
of
1992
Number
3495
on
to
Health
State
Number
3671
to
State
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
4.
Law
Number
22
(Supplement
of
1997
Number
on
3698
Narcotics
to
State
on
Local
Law
Number
Government
32
of
2004
(Supplement
Number
3452
to
Medical
devices
(State
Gazette
Authorities
Provincial
of
Central
Government
as
and
Autonomous
Decree
of
Minister
of
131/Menkes/SK/II/2004
Health
on
Number
National
Health System;
9.
Decree
of
Minister
of
Health
Number
1575/Menkes/Per/XI/2005 on Organization
and
Task
Health;
Management
of
Ministry
of
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
HAS DECIDED :
To stipulate :
First
Second
Third
sustainability
availability,
fair
Upon
stipulation
Minister
hereof,
of
Health
47/Menkes/SK/II/1983
Medicines
Policy
Decree
is
on
hereby
of
Number
National
revoked
and
10
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
Appendix
Decree of Minister of Health
Number 189/MENKES/SK/III/2006
March 27, 2006
NATIONAL MEDICINES POLICY
I.
INTRODUCTION
A. BACKGROUND
The essential objectives of health development toward
Healthy
Indonesia
development
which
objectives
of
2010
has
directed
prioritizing
health
health
development
the
health
paradigm.
toward
The
Healthy
to
realize
healthy
living
and
to
have
services.
mixture
of
investigate
condition
healing,
Medicine
materials
determining
recovery
and
applied
physiological
in
is
single
to
system
bear
or
diagnosis,
development
of
material
or
effect
or
pathological
prevention,
health
and
11
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
Medicine
is
totally
different
from
other
trade
Government
policy
on
the
improvement
of
medicine
to
Decree
of
Minister
of
Health
governing
the
administration,
communities
and
business
2004
subsystem
includes
Medicines
and
Medical
Supply.
In
the
subsystem,
availability
affordability,
of
there
is
medicines,
safety,
strong
fair
efficacy
and
emphasis
on
distribution,
quality
of
medicines.
12
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
by
stipulating
the
new
National
Medicines
Policy.
which
sets
forth
the
commitment
of
all
of
essential
on
medicines
other
including
relevant
components
parties
of
policy
the
strategy
and
in
applying
the
achieving
the
in
Developing
medicines
for
countries
in
primary
providing
health
have
utilized
traditional
health
services
particularly
care.
The
use
of
traditional
by
realizing
that
medicinal
plants
necessary
to
adequate
research.
Indonesia
in
prepare
the
is
world,
National
13
the
Considering
mega
it
center
and
of
is
consider
Traditional
Medicines
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
Law
No
22/1999
as
amended
and
renewed
by
Law
caused
provision
and
or
budget
management
for
The
implementation
of
local
autonomy
has
created
of
essential
communities
is
boundaries,
islands
necessary
to
maintained.
and
develop
medicines
For
remote
disaster
specific
for
places,
areas,
medicines
the
it
is
management
system.
B. OBJECTIVES
National
assuring
Policy
on
Medicine
sustainable
14
fair
is
broadly
aimed
distribution
at
and
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
affordability
of
medicines
to
achieve
the
highest
Sustainable
affordability
and
Rational
Use
of
prioritizing
supply
of
essential
medicines
will
The
safety,
efficacy
and
quality
of
all
medicines
benefits.
Accordingly,
communities
must
be
2.
Safety,
efficacy
and
public
protection
quality
from
of
misuse
medicines
and
abuse
and
of
medicines.
3.
C. SCOPE
The
scope
development
course
of
of
National
of
Medicines
medicines
health
to
development
human resources.
15
Policy
achieve
in
the
covers
the
effective
generating
quality
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
National
Medicines
availability
selection
and
of
Medicines,
fair
medicines,
and
human
include
distribution,
essential
control
development,
Policy
financing,
affordability,
Rational
administration,
resource
Use
research
development,
of
and
monitoring
and evaluation.
II.
availability
elements
disease
in
of
health
prevention,
medicine
as
program,
i.e,
diagnosis,
one
of
the
health
medication
essential
maintaining,
and
recovery
and
harmful
effect
caused
by
sub-standard
Besides,
medicine
is
an
important
element
for
health
economic
recent
aspects
globalization,
minimized
medicines
in
can
such
be
have
increased
however,
way
that
accommodated
16
in
with
the
demand
can
be
communities
need
of
this
and
line
pharmaceutical
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
A. DEVELOPMENT
252
million
inhibitants
with
the
following
tendencies.
the
decline
of
fertility
and
mortality,
the
and
workforce
infants,
and
and
orphans
significant
(geriatric)
in
increase
2025,
of
which
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
Use
of
Medicines,
affordable
price,
supply
system
distribution
and
assuring
the
availability,
affordability.
fair
Interventions
on
in
1997
has
shown
that
the
Rational
Use
of
18
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
standards
standards,
have
been
efficacy
set
and
up
which
quality.
include
Besides,
government
through
supply
Pharmaceutical
Warehouse
function
Government
of
system
by
Facilities.
The
Pharmaceutical
Government
role
and
Warehouse
perspectives
of
the
local
governments
in
by
Industry,
Pharmaceutical
Wholesalers,
To
assure
medicines,
sustainable
the
affordability
government
19
has
fixed
of
the
essential
price
of
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
essential
medicines
low-income
for
communities
health
have
services.
been
Meanwhile,
subsidized
through
National
Essential
Medicines
List
(NEDL)
has
been
has
medicines
reached
prescribed
above
in
80%
and
Community
more
Health
than
90%
Center
are
essential medicines.
High
profile
of
essential
medicines
use
in
primary
government
hospital
condition
49%
hospital
and
above
was
less
pharmacies
demonstrated
below
less
that
76%,
than
the
private
47%.
concept
The
of
20
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
Availability
of
narcotics
for
health
services
is
B. ISSUES
In
the
context
of
economic
affordability,
medicines
WHO
research
showed
that
the
comparison
of
price
generally
lower
at
price
compared
to
brandname
medicines.
21
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
The
pricing
mechanism
of
medicine
price
in
private
In
recent
years,
some
Government
Pharmaceutical
availability
of
competent
personnel,
Government
Pharmaceutical
Installation
are
listed
in
National
400 types of
Essential
Medicine
health
care,
the
availability
of
generic
regulation
stating
22
that
procurement
of
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
medicine
which
sourced
from
Local
Budget
or
State
availability
of
medicine
is
supported
by
Java
islands,
manufacturing
98%
of
national
will
affect
unstable
supply
of
national
multi-national pharmaceutical
industries to merge and the implementation of TradeRelated Aspects of Intellectual Property Rights (TRIPs),
there is anxiety that national pharmaceutical industry
will
find
it
difficult
to
compete
in
the
domestic
decentralization
era,
the
allocation
of
23
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
government
through
Fund
by
Presidential
to
US$
0,85
per
capita.
At
present,
government
therefore,
care
is
the
the
medicine
budget
responsibility
of
for
primary
the
local
region
is
different
from
others
thanks
to
the
In
spite
of
this,
the
government
will
be
24
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
(PKPS-BBM)
at
approximate
value
of
Rp.
160
the
government
appointed
by
the
allocation
for
or
private
government.
medicine
health
At
provision
facilities
present,
in
budget
primary
health
medication
period
at
affordable
cost.
The
common
pharmacy,
Irrational
use
antimicrobial
of
use,
Use
of
non-essential
excessive
Medicines
medicines,
use
of
are
poly-
improper
injection,
and
malaria
are
predicted
increase.
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
will
prevail
as
at
present.
Measles,
through
The
prevalence
of
non-communicable
diseases
such
as
aimed
at
increasing
the
Rational
Use
of
properly
performed
almost
in
all
second-level
availability,
fair
distribution
and
lack
26
of
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
C. OPPORTUNITIES
The
number
of
pharmaceutical
industries
are
availability
of
medicines
mainly
essential
manufactured
of
generic
distribution
essential
available
medicines.
from
the
The
central,
to
ensure
the
availability
of
medicines.
of
medicines,
administration
and
control
of
medicines.
year,
Pharmacists.
pharmacy
schools
Likewise,
27
the
generated
about
availability
of
2000
D-3
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
Assistant
to
Pharmacist
mostly
required
in
primary healthcare.
facility
medication.
showed
of
Data
that
health
from
83,88%
services
Family
of
Health
populations
but
also
Survey
self-
in
performed
2001
self-
D. CHALLENGES
For
the
last
one
and
half
decade,
the
worlds
number
of
trans-national
companies.
The
ten
prevail
countries,
in
rapidly
two
most
growing
domestic market.
28
densely-populated
in
very
Asian
competitive
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
medicines
will
pharmaceutical
distribution
diseases
be
influenced
companies
of
which
at
global
communicable
must
carefully
and
by
the
scale
role
and
of
global
non-communicable
thought
by
Indonesia
since now.
through
harmonization
of
technical
initiated
by
industrial
countries.
Technical
five
Agreement
agreements
on
relevant
Trade-Related
to
Aspects
health
of
sector,
Intellectual
and
Trade
(GATT);
29
and
General
Agreement
on
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
WTO
Agreements
brought
implications
of
patent
right
of
registration
process
and
conditions
have
burdened
the
control
and
competitiveness.
Agreement
on
TRIP
extended
the
bearing
affordability.
adverse
For
that
impact
on
reason,
the
public
medicine
government
must
assure
the
availability
and
affordability
of
medicine in Indonesia.
Synchronization
of
technical
requirements
will
bear
Therefore,
Indonesia
must
face
such
not
meeting
30
the
required
standards.
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
Anticipating
such
threats,
the
control
and
capacity
in
harmony
with
science
and
of
medicines
geographical,
economic,
can
be
perceived
from
aspects.
Some
socio-politic
and
disaster-prone
areas.
Through
the
to
medicines
management
as
per
representing
the
elaboration
of
the
National
31
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
2. Government
is
affordability
responsible
and
fair
for
the
distribution
availability,
of
essential
and
Health
for
assuring
responsible
Service
Providers
rational
are
medication
or
control
and
must
present
guidance,
are
held
responsible
for
the
quality
of
control
and
responsibilities
administration
of
government
must
being
be
the
assumed
in
information
must
the
empower
on
medicines.
communities
in
Government
decision-taking
process on medicines.
B.
STRATEGY
1. Availability, Fair Distribution and Affordability
of Essential Medicines.
influenced
Use
of
by
four
Medicines,
32
primary
affordable
factors;
price,
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
sustainable
financing,
healthcare
system
and
Taking
into
account
the
foregoing,
the
a. Sustainable
financing
of
medicine
supply,
in
public
effective,
efficient
distribution
of
sector
and
medicines
including
accountable
in
public
and
private sectors.
d. Continuous
development
and
evaluation
management
areas,
remote
boundary
disaster-prone areas.
33
in
areas,
areas
and
undernatural
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
commodities
to
facilitate
the
2. Safety
Assurance,
distributed
efficacy
medicines
and
including
quality
the
of
community
such
objectives,
the
following
a.
Evaluation
through
on
safety,
registration,
efficacy
guidance,
and
quality
control
and
34
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
c.
Deregulation
on
production
facilities,
Community
empowerment
dissemination
of
through
reliable
supply
information
and
to
and
implementation
of
therapy
is
misleading
information.
safety
for
providers
the
users,
or
incorrect,
incomplete
Therefore,
either
communities
assurance
healthcare
will
and
on
service
receive
correct,
efforts
use
of
shall
medicine
be
made
through
to
the
assure
following
strategies:
a.
Application
List
in
of
each
35
National
health
Essential
service,
Medicine
personal
or
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
best-scientifically
proven
based
formularies.
b.
Health
reference
to
Security
National
(JKN)
National
scheme
by
Essential
cost-effective
analysis
and
cost-
e.
Community
Empowerment
through
communication,
MEDICINE FINANCING
Goal
Community, mostly poor communities will have access
to essential medicines at any time necessary.
The
primary
factor
assuring
the
availability
of
and
sustainable
financing.
Sufficient
36
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
to
public
if
public
health
services
scale
(WHO
recommended
minimum
3.
Supply
of
medicine
budget
for
national
health
programs.
4.
for
disaster
control
and
to
fulfill
6.
System
must
services.
37
implement
full
healthcare
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
7.
8.
The
mechanism
of
medicine
aid
must
comply
with
B.
essential
medicines
at
national
level
Government
must
facilitate
local
companies
with
be
continuously
developed
in
support
of
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
Grant
of
incentives
to
domestic
manufacturing
use
of
existing
opportunities
under
WTO
Agreements.
2.
Increasing
medicine
production
scale
exports
to
to
promote
economic
the
growth
of
cooperation,
public
and
national economy.
3.
Expansion
private,
of
in
regional
support
of
international
medicine
natural
resources
as
per
criteria
Improvement
of
distribution
regulations
effective
of
on
medicine
availability,
and
through
efficient
proper
affordability
and
Improvement
of
professionalism
pharmacy
of
services
pharmaceutical
39
through
personnel
as
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
7.
Grant
of
incentives
for
medicine
service
in
remote areas.
8.
Development
of
monitoring
scheme
of
essential
Provincial
and
Regency/City
level
and
medicines
management
unit
by
utilizing
of
efficient
principles
in
procurement
and
bulk
procurement
at
regency/city level.
c. Good
Medicines
Management
in
Pharmaceutical
40
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
subject
to
the
applicable
rules
and
regulations.
b. Preparation of guideline on medicine supply in
emergency case must be periodically reviewed.
c. Supply
of
medicine
in
emergency
case
must
must
adopt
measures
to
assure
of
medicine
and
in
remote
disaster-prone
areas,
areas
boundary
and
orphan
AFFORDABILITY
Goal :
Price
affordability
of
essential
medicines
to
at
realizing
affordability
the
communities.
The
efforts
aimed
accessibility
to
medicines
shall
be
made
from
or
two
demand,
implemented
and
Essential
use
of
41
Medicine
generic
Concept
medicines
will
be
through
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
each
level
of
healthcare
services,
regulation,
Meanwhile,
the
implementation
of
National
Health
mainly
the
essential
medicines.
implementation
of
JKN
For
that
must
be
continuously maximized.
medicines
and
development
of
price
human
rights,
essential
medicines
must
be
Policy Steps:
1. Maximized
implementation
of
Essential
Medicine
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
b.
List
(DOEN)
at
all
levels
of
healthcare services.
c.
d.
Consistent
and
continuous
dissemination
of
generic medicines.
e.
Controlling
over
generic
utilizing
information
medicine
on
price
by
international
medicine price.
f.
comparison
of
urban
and
village
and
on
impact
of
policy
on
medicine
price.
3. Use of pharmacy-economic approaches in healthcare
service units to maximize efficiency.
4. Implementation of statutory license of medicines
in
accordance
with
regulations.
43
the
prevailing
laws
and
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
5. Development
of
information
system
on
medicine
price.
6. Development of effective and efficient medicines
procurement system, public and private.
7. Exemption from tax and import duty for essential
medicines.
8. Regulation
on
price
of
essential
medicines
to
with
the
scientific
development
for
wide
Essential
for
medicine
healthcare
is
selected
services
medicines
including
necessary
diagnosis,
continuously
quantity,
proper
available
stocks,
in
adequate
assured
quality,
44
type
and
adequate
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
will
not
reflect
the
actual
need
and
process
transparency,
must
clear
include
selection
consultancy,
guideline,
proper
of
with
essential
the
medicines
therapy
must
guideline
or
be
in
standard
of
essential
medicines
shall
be
made
clinicians
and
public
health
of
National
Essential
Medicine
List
(DOEN) shall be made periodically at minimum of 34 years through similar decision-taking process.
4. Dissemination
of
DOEN
to
public
health
service
45
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
education
institution,
either
in
printed
or
electronic media.
E.
In
dealing
with
irrational
use
of
medicines,
the
systematically
made
at
all
levels
of
health
Policy Steps:
1.
The
preparation
of
best-scientific
proven
46
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
3.
Formation
and/or
Empowerment
of
Pharmacy
and
Clinic-based
pharmacotherapy
University
degree
learning
curriculum
for
in
health
professionals.
5.
Sustainable
education
requirements
for
as
one
of
granting
the
mandatory
license
and
7.
Supply
of
accurate,
information
centers
on
at
full
medicines
public
and
and
non-misleading
through
information
private
healthcare
facilities.
8.
appropriate
use
of
medicines
and
building
Regulation
and
implementation
to
prevent
from
of
rational
and
medicine
continuous
use
through
communication,
47
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
F.
MEDICINES CONTROL
Goal:
1.
Distributed
medicines
must
fulfill
the
Medicines
control
involves
the
is
very
stakeholders
complex
i.e.
task
which
government,
be
satisfactorily
perform
such
resources
met
control
and
by
e.q.
adequate
government
legal
agency
grounds,
financial
to
human
resources,
independent
and
transparent
quality
examination laboratory.
48
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
Policy Steps:
1. Assessment and Registration of Medicines.
2. Preparation
and
implementation
of
product
and
certification
of
production
and
distribution facilities.
4. Inspection
on
production
and
distribution
facilities.
5. Quality test by accredited laboratory.
6. Monitoring over Medicine promotion
7. Post-marketing surveillance and vigilance.
8. Re-assessment on distributed medicines.
9. Improvement of facilities and infrastructures of
medicines
control
and
administration
and
of
and
Medicine
local
Information
levels
for
Center
at
intensified
over
counterfeit
and
smuggled
substandard,
49
counterfeit
and
illegal
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
of
implementation
of
National
Medicines
Policy.
Research and development of medicines
is aimed at
on
financing,
distribution,
medicines,
availability
affordability,
rational
use
selection
of
and
fair
of
essential
medicines,
control,
Identification
priority
by
of
relevant
close
work
study
mechanism
and
setting
between
the
Improvement
cooperation
medicines
of
on
and
synchronization
cross-sector
research
improvement
of
and
of
research
and
foreign
development
of
coordination
and
among
various
50
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
3.
H.
of
in
reliable
promoting
and
the
qualified
goals
of
human
National
Medicines Policy.
Human Resources required in various institutions must
be
adequate
in
terms
distribution. In this
improve
and
develop
of
quantity,
competency
or
respect, it is necessary to
Human
Resources
on
Health
in
of
Regency/City
(IFK)
furnished
with
to
supply
adequate
and
competent
human
resources.
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
supply
and
distribution
of
pharmaceutical
of
National
curriculum
Medicines
and
training
Policy
for
into
health
professionals.
4. Integration
continuous
of
National
education
Medicines
by
health
Policy
into
professional
organizations.
5. Strengthening national, regional and international
cooperation for human resource development.
I.
on
performance
and
policy
impact
to
52
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
This
is
important
to
make
prompt
anticipation
or
of
activities
Necessary
related
corrections
to
will
policy
be
development.
based
on
policy
monitoring.
Evaluation on policy is aimed at gaining information
on
implementation,
output
reporting,
outcome
Monitoring
and
evaluation
is
periodically
Implementation
comply
and
monitoring
with
WHO
collaboration
with
concerned
compare
to
indicators
recommendation
WHO
the
or
and
other
results
must
in
parties
to
other
countries.
3.
53
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
c. Discussion
materials
with
international
CLOSING
The
successful
implementation
of
National
Medicines
integrity,
persistence,
hard
work
and
The
implementation
require
of
National
organization,
Medicines
mobilization,
Policy
will
monitoring,
and
at
inter-dependent
dynamic
local,
global level.
54
system
national,
by
strategic
regional
and
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
CONTRIBUTORS
The completion of National Medicines Policy is realized by
support of active participation of the following parties:
National Medicines Policy Team formed by virtue of Decree
of
Minister
of
Health
Number
1273/Menkes/SK/XII/2004
on
Person in charge
: Minister of Health
: Director
of
Pharmaceutical
Health
of
RI,
2)
Director
Director
Elimination
Diseases
Health,
Agency
6)
of
5)
Environmental
Head
and
of
Health
Head
of
of
Health
of
Communicable
and
Development
for
General
Research
Development,
Research
Human
and
Resources
Professionals,
7)
Drug
Secretary
55
Control,
of
NA-FDC,
8)
Chief
9)
Deputy
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
of
Traditional
Cosmetics
Medicines
and
and
Complimentary
and
Safety
Hazardous
of
Ministerial
of
Material
NA-FDC,
Expert
11)
Staff
Institutional
(MES)
Capacity
13)
MES
of
14)
Vulnerable
MES
Community
of
Health
Service;
Executive Team, Chairman
Deputy Chairman
: Deputy
Narcotic,
Additive
of
Therapeutic
Psychotropic
Substances
Control
and
and
of
NA-FDC.
Secretary
: 1)
Secretary
General
of
of
Directorate
Pharmaceutical
56
of
Medicine
and
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
Biological
3)
Head
of
Traditional
Products
of
NA-FDC,
Pharmaceutical
Medicine
and
Research
2)
Director
of
Production
and
Distribution
Therapeutic
FDC
6)
Director
Product
FDC,
Products
of
Head
of
NA-
Therapeutic
Standardization
7)
of
of
NA-
Planning
and
Head
of
Research
Health,
Health
Center
9)
Development
of
Head
of
Ministry
of
Legal
and
Organization Bureau.
Consultants
57
DR.
Drs.
Charles
JP
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
Siregar,
Apt,
3)
DR.
Dra.
Sri
Suryawati, Apt.
Chairman
: Drs.
Richard
Panjaitan,
Apt,
SKM;
Members
Drs.
Slamet
Soesilo,
Apt
JP
(Consultant),
Siregar,
6)
DR.
Dra.
Apt
Sri
Secretariat of
virtue
of
58
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
Coordinator
Members
: 1)
Drs.
M.Kes,
M
2)
Nur
Ginting,
Apt,
Dra.
Chusun,
Apt,
Apt,
Abdullah
MPharm,
Achmad,
MARS,
4)
dr.
5)
Dra.
wurjati,
Apt,
7)
Drs.
: 1)
Dra.
Sukarni,
Apt,
2)
Dra.
Dra
SSi,
Haryono,
Apt,
5)
4)
Riani
Mindawati,
Trienawati,
on
discussion
topics
1).
National
Essential
After
Decentralization
59
and
Revitalization
of
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
of
Health:
Echelon-I
Minister
Officials,
of
Chief
Health,
Researcher
Echelon-I
on
Health
Beyond
Ministry
of
Health:
Association
Organizations
Representative
of
Higher
on
Schools
Consumer
(Faculty
of
Protection,
Medicine
and
Faculty of Pharmacy).
National Seminar/Workshop:
Drs. Slamet Soesilo, Apt, Prof. DR. Drs. Charles JP Siregar,
Apt,
DR.
Dra.
Sri
Suryawati,
Apt.
Head
of
Health
Lombok
Regency,
Head
of
Health
Agency
of
Cirebon
Regency,
Head
of
Health
Agency
of
Bekasi
City,
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
Prof
Soekarjo
Muhammadiyah
Central
Yogyakarta,
Java,
Hospital
Director
of
Director
PKU
dr.
Hospital
M.
Djamil
of
Adam
Malik
Medan,
Public
Hospital
dr.
Wahidin
Pharmacy
Depok,
Department
of
Pharmacy
of
Bandung
of
Faculty
of
Medicines
UGM),
Director
of
JPKM
of
(Persero),
Faculty
Health
ISFI,
of
of
IDI,
RI,
Operating
PDGI,
Pharmacy,
PAFI
Director
Hisfarsi,
Association
of
of
PT
Association
of
Pharmaceutical
61
ASKES
MINISTER OF HEALTH
REPUBLIC OF INDONESIA
All
parties
supporting
the
preparation
of
KONAS
not
mentioned herein.
I, Eko Tjahyadi Sworn & Certified Translator, hereby declare that this document is an English
translation of a document prepared in Indonesian language. In translating this document an attempt has
been made to translate as literally as possible without jeopardizing the overall continuity of the text.
However differences may occur in translation and if they do the original text has precedence in law.
62